{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T12:26:31Z","timestamp":1788956791332,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-13762-4","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T04:04:12Z","timestamp":1740542652000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["RhoB regulates prostate cancer cell proliferation and docetaxel sensitivity via the PI3K-AKT signaling pathway"],"prefix":"10.1186","volume":"25","author":[{"given":"Tiantian","family":"Sheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjuan","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,26]]},"reference":[{"key":"13762_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2017.09.002","volume":"183","author":"S Jansen","year":"2018","unstructured":"Jansen S, Gosens R, Wieland T, Schmidt M. Paving the Rho in cancer metastasis: Rho GTPases and beyond. Pharmacol Ther. 2018;183:1\u201321.","journal-title":"Pharmacol Ther"},{"issue":"4","key":"13762_CR2","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1080\/10409238.2020.1810622","volume":"55","author":"RG Hodge","year":"2020","unstructured":"Hodge RG, Schaefer A, Howard SV, Der CJ. RAS and RHO family GTPase mutations in cancer: twin sons of different mothers? Crit Rev Biochem Mol Biol. 2020;55(4):386\u2013407.","journal-title":"Crit Rev Biochem Mol Biol"},{"issue":"5","key":"13762_CR3","doi-asserted-by":"publisher","first-page":"1766932","DOI":"10.1080\/23723556.2020.1766932","volume":"7","author":"K Zaoui","year":"2020","unstructured":"Zaoui K, Smith HW, Park M, Duhamel S. ARF6 controls RHOB targeting to endosomes regulating cancer cell invasion. Mol Cell Oncol. 2020;7(5):1766932.","journal-title":"Mol Cell Oncol"},{"issue":"2","key":"13762_CR4","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/35101096","volume":"1","author":"GC Prendergast","year":"2001","unstructured":"Prendergast GC. Actin\u2019 up: RhoB in cancer and apoptosis. Nat Rev Cancer. 2001;1(2):162\u20138.","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"13762_CR5","doi-asserted-by":"publisher","first-page":"818","DOI":"10.3390\/cancers11060818","volume":"11","author":"E Gutierrez","year":"2019","unstructured":"Gutierrez E, Cahatol I, Bailey CAR, Lafargue A, Zhang N, Song Y, Tian H, Zhang Y, Chan R, Gu K, Zhang ACC, Tang J, Liu C, Connis N, Dennis P, Zhang C. Regulation of RhoB gene expression during tumorigenesis and aging process and its potential applications in these processes. Cancers (Basel). 2019;11(6):818.","journal-title":"Cancers (Basel)"},{"issue":"5","key":"13762_CR6","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1038\/sj.onc.1207236","volume":"23","author":"K Jiang","year":"2004","unstructured":"Jiang K, Delarue FL, Sebti SM. EGFR, ErbB2 and Ras but not Src suppress RhoB expression while ectopic expression of RhoB antagonizes oncogene-mediated transformation. Oncogene. 2004;23(5):1136\u201345.","journal-title":"Oncogene"},{"issue":"1","key":"13762_CR7","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12943-022-01587-9","volume":"21","author":"J Gu","year":"2022","unstructured":"Gu J, Huang W, Wang X, Zhang J, Tao T, Zheng Y, Liu S, Yang J, Chen ZS, Cai CY, Li J, Wang H, Fan Y. Hsa-miR-3178\/RhoB\/PI3K\/Akt, a novel signaling pathway regulates ABC transporters to reverse gemcitabine resistance in pancreatic cancer. Mol Cancer. 2022;21(1):112.","journal-title":"Mol Cancer"},{"key":"13762_CR8","doi-asserted-by":"crossref","unstructured":"Ju JA, Gilkes DM. RhoB: team oncogene or team tumor suppressor?? Genes (Basel). 2018, 9(2):67.","DOI":"10.3390\/genes9020067"},{"issue":"3","key":"13762_CR9","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/jmi.12025","volume":"251","author":"AJ Ridley","year":"2013","unstructured":"Ridley AJ. RhoA, RhoB and RhoC have different roles in cancer cell migration. J Microsc. 2013;251(3):242\u20139.","journal-title":"J Microsc"},{"issue":"1","key":"13762_CR10","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1152\/physrev.00045.2020","volume":"102","author":"E Crosas-Molist","year":"2022","unstructured":"Crosas-Molist E, Samain R, Kohlhammer L, Orgaz JL, George SL, Maiques O, Barcelo J, Sanz-Moreno V. Rho GTPase signaling in cancer progression and dissemination. Physiol Rev. 2022;102(1):455\u2013510.","journal-title":"Physiol Rev"},{"issue":"2","key":"13762_CR11","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/nrc.2017.118","volume":"18","author":"T Brabletz","year":"2018","unstructured":"Brabletz T, Kalluri R, Nieto MA, Weinberg RA. EMT in cancer. Nat Rev Cancer. 2018;18(2):128\u201334.","journal-title":"Nat Rev Cancer"},{"issue":"14","key":"13762_CR12","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1038\/onc.2015.240","volume":"35","author":"E Bousquet","year":"2016","unstructured":"Bousquet E, Calvayrac O, Mazi\u00e8res J, Lajoie-Mazenc I, Boubekeur N, Favre G, Pradines A. RhoB loss induces Rac1-dependent mesenchymal cell invasion in lung cells through PP2A Inhibition. Oncogene. 2016;35(14):1760\u20139.","journal-title":"Oncogene"},{"issue":"1","key":"13762_CR13","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1159\/000489917","volume":"47","author":"N Zacharopoulou","year":"2018","unstructured":"Zacharopoulou N, Tsapara A, Kallergi G, Schmid E, Alkahtani S, Alarifi S, Tsichlis PN, Kampranis SC, Stournaras C. The epigenetic factor KOM2B regulates EMT and small GTPases in Colon tumor cells. Cell Physiol Biochem. 2018;47(1):368\u201377.","journal-title":"Cell Physiol Biochem"},{"issue":"4","key":"13762_CR14","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1080\/21541248.2016.1234429","volume":"9","author":"O Calvayrac","year":"2018","unstructured":"Calvayrac O, Pradines A, Favre G. RHOB expression controls the activity of serine\/threonine protein phosphatase PP2A to modulate mesenchymal phenotype and invasion in non-small cell lung cancers. Small GTPases. 2018;9(4):339\u201344.","journal-title":"Small GTPases"},{"issue":"7","key":"13762_CR15","doi-asserted-by":"publisher","first-page":"e0157599","DOI":"10.1371\/journal.pone.0157599","volume":"11","author":"W Chen","year":"2016","unstructured":"Chen W, Niu S, Ma X, Zhang P, Gao Y, Fan Y, Pang H, Gong H, Shen D, Gu L, Zhang Y, Zhang X. RhoB acts as a tumor suppressor that inhibits malignancy of clear cell renal cell carcinoma. PLoS ONE. 2016;11(7):e0157599.","journal-title":"PLoS ONE"},{"issue":"10","key":"13762_CR16","first-page":"1935","volume":"10","author":"G Zalcman","year":"1995","unstructured":"Zalcman G, Closson V, Linar\u00e8s-Cruz G, Lerebours F, Honor\u00e9 N, Tavitian A, Olofsson B. Regulation of Ras-related RhoB protein expression during the cell cycle. Oncogene. 1995;10(10):1935\u201345.","journal-title":"Oncogene"},{"issue":"11","key":"13762_CR17","doi-asserted-by":"publisher","first-page":"6192","DOI":"10.1073\/pnas.111137198","volume":"98","author":"AX Liu","year":"2001","unstructured":"Liu AX, Cerniglia GJ, Bernhard EJ, Prendergast GC. RhoB is required to mediate apoptosis in neoplastically transformed cells after DNA damage. Proc Natl Acad Sci U S A. 2001;98(11):6192\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"13762_CR18","doi-asserted-by":"publisher","first-page":"4139","DOI":"10.1038\/s41467-018-06556-9","volume":"9","author":"M Liu","year":"2018","unstructured":"Liu M, Zeng T, Zhang X, Liu C, Wu Z, Yao L, Xie C, Xia H, Lin Q, Xie L, Zhou D, Deng X, Chan HL, Zhao TJ, Wang HR. ATR\/Chk1 signaling induces autophagy through sumoylated RhoB-mediated lysosomal translocation of TSC2 after DNA damage. Nat Commun. 2018;9(1):4139.","journal-title":"Nat Commun"},{"issue":"1","key":"13762_CR19","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1038\/s41467-021-22726-8","volume":"12","author":"C Miao","year":"2021","unstructured":"Miao C, Yu M, Pei G, Ma Z, Zhang L, Yang J, Lv J, Zhang ZS, Keller ET, Yao Z, Wang Q. An infection-induced RhoB-Beclin 1-Hsp90 complex enhances clearance of uropathogenic Escherichia coli. Nat Commun. 2021;12(1):2587.","journal-title":"Nat Commun"},{"issue":"12","key":"13762_CR20","doi-asserted-by":"publisher","first-page":"e8117","DOI":"10.1371\/journal.pone.0008117","volume":"4","author":"D P\u00e9rez-Sala","year":"2009","unstructured":"P\u00e9rez-Sala D, Boya P, Ramos I, Herrera M, Stamatakis K. The C-terminal sequence of RhoB directs protein degradation through an endo-lysosomal pathway. PLoS ONE. 2009;4(12):e8117.","journal-title":"PLoS ONE"},{"issue":"1","key":"13762_CR21","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KO, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"13762_CR22","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1007\/s11427-022-2218-x","volume":"66","author":"W Ju","year":"2023","unstructured":"Ju W, Zheng R, Zhang S, Zeng H, Sun K, Wang S, Chen R, Li L, Wei W, He J. Cancer statistics in Chinese older people, 2022: current burden, time trends, and comparisons with the US, Japan, and the Republic of Korea. Sci China Life Sci. 2023;66(5):1079\u201391.","journal-title":"Sci China Life Sci"},{"issue":"1","key":"13762_CR23","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1038\/s41467-021-21976-w","volume":"12","author":"B Zhang","year":"2021","unstructured":"Zhang B, Li Y, Wu Q, Xie L, Barwick B, Fu C, Li X, Wu D, Xia S, Chen J, Qian WP, Yang L, Osunkoya AO, Boise L, Vertino PM, Zhao Y, Li M, Chen HR, Kowalski J, Kucuk O, Zhou W, Dong JT. Acetylation of KLF5 maintains EMT and tumorigenicity to cause chemoresistant bone metastasis in prostate cancer. Nat Commun. 2021;12(1):1714.","journal-title":"Nat Commun"},{"issue":"1","key":"13762_CR24","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/s41420-021-00764-x","volume":"7","author":"Y Zheng","year":"2021","unstructured":"Zheng Y, Li P, Huang H, Ye X, Chen W, Xu G, Zhang F. Androgen receptor regulates eIF5A2 expression and promotes prostate cancer metastasis via EMT. Cell Death Discov. 2021;7(1):373.","journal-title":"Cell Death Discov"},{"issue":"8","key":"13762_CR25","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/cr.2014.87","volume":"24","author":"J Duan","year":"2014","unstructured":"Duan J, Lu G, Xie Z, Lou M, Luo J, Guo L, Zhang Y. Genome-wide identification of CRISPR\/Cas9 off-targets in human genome. Cell Res. 2014;24(8):1009\u201312.","journal-title":"Cell Res"},{"issue":"15","key":"13762_CR26","doi-asserted-by":"publisher","first-page":"6092","DOI":"10.1158\/0008-5472.CAN-08-4147","volume":"69","author":"E Bousquet","year":"2009","unstructured":"Bousquet E, Mazi\u00e8res J, Privat M, Rizzati V, Casanova A, Ledoux A, Mery E, Couderc B, Favre G, Pradines A. Loss of RhoB expression promotes migration and invasion of human bronchial cells via activation of AKT1. Cancer Res. 2009;69(15):6092\u20139.","journal-title":"Cancer Res"},{"issue":"3","key":"13762_CR27","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.ymthe.2016.12.018","volume":"25","author":"M Sun","year":"2017","unstructured":"Sun M, Nie FQ, Zang C, Wang Y, Hou J, Wei C, Li W, He X, Lu KH. The pseudogene DUXAP8 promotes Non-small-cell lung Cancer cell proliferation and invasion by epigenetically Silencing EGR1 and RHOB. Mol Ther. 2017;25(3):739\u201351.","journal-title":"Mol Ther"},{"key":"13762_CR28","doi-asserted-by":"publisher","first-page":"e1164","DOI":"10.1002\/cnr2.1164","volume":"3","author":"JA Ju","year":"2020","unstructured":"Ju JA, Godet I, DiGiacomo JW. GilkesDM. RhoB is regulated by hypoxia and modulates metastasis inbreast cancer. Cancer Rep. 2020;3:e1164.","journal-title":"Cancer Rep"},{"key":"13762_CR29","doi-asserted-by":"publisher","first-page":"114392","DOI":"10.1016\/j.biopha.2023.114392","volume":"160","author":"M Hashemi","year":"2023","unstructured":"Hashemi M, Zandieh MA, Talebi Y, Rahmanian P, Shafiee SS, Nejad MM, Babaei R, Sadi FH, Rajabi R, Abkenar ZO, Rezaei S, Ren J, Nabavi N, Khorrami R, Rashidi M, Hushmandi K, Entezari M, Taheriazam A. Paclitaxel and docetaxel resistance in prostate cancer: molecular mechanisms and possible therapeutic strategies. Biomed Pharmacother. 2023;160:114392.","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"13762_CR30","doi-asserted-by":"publisher","first-page":"238","DOI":"10.15252\/emmm.201606646","volume":"9","author":"O Calvayrac","year":"2017","unstructured":"Calvayrac O, Mazi\u00e8res J, Figarol S, Marty-Detraves C, Raymond-Letron I, Bousquet E, Farella M, Clermont-Taranchon E, Milia J, Rouquette I, Guibert N, Lusque A, Cadranel J, Mathiot N, Savina A, Pradines A, Favre G. The RAS-related GTPase RHOB confers resistance to EGFR-tyrosine kinase inhibitors in non-small-cell lung cancer via an AKT-dependent mechanism. EMBO Mol Med. 2017;9(2):238\u201350.","journal-title":"EMBO Mol Med"},{"issue":"1","key":"13762_CR31","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12935-024-03236-1","volume":"24","author":"M Kopsida","year":"2024","unstructured":"Kopsida M, Liu N, Kotti A, Wang J, Jensen L, Jothimani G, Hildesjo C, Haapaniemi S, Zhong W, Pathak S, Sun XF. RhoB expression associated with chemotherapy response and prognosis in colorectal cancer. Cancer Cell Int. 2024;24(1):75.","journal-title":"Cancer Cell Int"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-13762-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-13762-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-13762-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T04:04:16Z","timestamp":1740542656000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-13762-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,26]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13762"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-13762-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5198679\/v1","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,26]]},"assertion":[{"value":"3 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All experiments including animal experiments were approved by the Ethics Committee of Jining No.1 People\u2019s Hospital approved this study (License No. JNRM-2022-DW-062). No human experiments were conducted in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}},{"value":"N\/A.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"N\/A.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Registry and the registration no. of the study\/trial"}},{"value":"Yes.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal studies"}},{"value":"All authors have consented to publication of this manuscript. All authors have read and approved the manuscript.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"354"}}